Perspectives on Bulk-Tissue RNA Sequencing and Single-Cell RNA Sequencing for Cardiac Transcriptomics

Front Mol Med. 2022 Feb 22:2:839338. doi: 10.3389/fmmed.2022.839338. eCollection 2022.

Abstract

The heart has been the center of numerous transcriptomic studies in the past decade. Even though our knowledge of the key organ in our cardiovascular system has significantly increased over the last years, it is still not fully understood yet. In recent years, extensive efforts were made to understand the genetic and transcriptomic contribution to cardiac function and failure in more detail. The advent of Next Generation Sequencing (NGS) technologies has brought many discoveries but it is unable to comprehend the finely orchestrated interactions between and within the various cell types of the heart. With the emergence of single-cell sequencing more than 10 years ago, researchers gained a valuable new tool to enable the exploration of new subpopulations of cells, cell-cell interactions, and integration of multi-omic approaches at a single-cell resolution. Despite this innovation, it is essential to make an informed choice regarding the appropriate technique for transcriptomic studies, especially when working with myocardial tissue. Here, we provide a primer for researchers interested in transcriptomics using NGS technologies.

Keywords: bulk-seq; heart; sequencing; single-cell; transcriptomics.

Publication types

  • Review

Grants and funding

LdW was funded by Dutch CardioVascular Alliance (ARENA-PRIME). LdW was further supported by a VICI award 918-156-47 from the Dutch Research Council and Marie Sklodowska-Curie grant agreements no. 813716 (TRAIN-HEART) and Marie Sklodowska-Curie grant agreements no. 765274 (iPlacenta). MS is funded by the DFG (RTG2220, Project 281125614) and Marie Skłodowska-Curie Grant Agreement 81371.